A PRS encompassing additional genetic variants derived from the most current AD GWA meta-analysis enriched the ability of APOE status to discern AD in a prospective community-based cohort followed over 17 years that was independent of previous GWA meta-analyses. The gene discussed is APOE; the disease is Alzheimer disease.